2021 SEP 15 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Amurthur, Badri (Los Gatos, CA, US), KenKnight, Bruce H. (Maple Grove, MN, US), Libbus, Imad (St. Paul, MN, US), filed on February 1, 2019, was published online on August 24, 2021. The patent's assignee for patent number 11097106 is LivaNovaUSA Inc. (Houston, Texas, United States). News editors obtained the following quote from the background information supplied by the inventors: "Congestive heart failure (CHF) and other forms of chronic cardiac dysfunction (CCD) are generally attributed to an autonomic imbalance of the sympathetic and parasympathetic nervous systems that, if left untreated, can lead to cardiac arrhythmogenesis, progressively worsening cardiac function and eventual patient death. CHF is pathologically characterized by an elevated neuroexcitatory state and is accompanied by physiological indications of impaired arterial and cardiopulmonary baroreflex function with reduced vagal activity.
展开▼
